(Total Views: 551)
Posted On: 02/06/2021 9:40:38 AM
Post# of 154115
Re: Rubraquercus #76617
I wondered if Leron/Vyro could be competitive on a financial basis with Keytruda and Opdivo.
Answer is yes. This from the Keytruda.com website:
And this is from BMS pricing dot com:
"The list price for an OPDIVO 360 mg and YERVOY 1 mg/kg infusion is $25,247 and the list price for an OPDIVO 360 mg alone infusion is $10,019. * However, most patients will pay less than the list price."
So that's another benefit via Leron. Costs a lot less.
Answer is yes. This from the Keytruda.com website:
Quote:
The list price for each indicated dose of KEYTRUDA when given every 3 weeks is $9,869.94. The list price for each indicated dose of KEYTRUDA when given every 6 weeks is $19,739.88. * The total cost of KEYTRUDA over the course of treatment is the same, whether given every 3 weeks or every 6 weeks.
And this is from BMS pricing dot com:
"The list price for an OPDIVO 360 mg and YERVOY 1 mg/kg infusion is $25,247 and the list price for an OPDIVO 360 mg alone infusion is $10,019. * However, most patients will pay less than the list price."
So that's another benefit via Leron. Costs a lot less.
(7)
(0)
